Your account is not claimed yet. You can sign up with ORCID to claim your account.

Dingxiao Zhang

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Venues

Cellular and molecular life sciences : CMLS

Cancer research

Molecular & cellular oncology

Journal of hematology & oncology

Hunan University

Chungbuk National University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hunan University Jul 9o 2019

China

Professor :: College of Biology

Education History

Chungbuk National University Sep 1o 2006 - Feb 2o 2010

South Korea

PHD :: Animal Science and Technology - Embryology

Publications

Chitra Rawat, Salma Ben-Salem, Nidhi Singh, Gaurav Chauhan, Anja Rabljenovic, Vishwa Vaghela, Varadha Balaji Venkadakrishnan, Jonathan D Macdonald, Ujjwal Ranjan Dahiya, Yara Ghanem, Salam P Bachour, Yixue Su, Adam D DePriest, Sanghee Lee, Michelle Muldong, Hyun Tae Kim, Sangeeta Kumari, Malyn May Valenzuela, Dingxiao Zhang, Qiang Hu, Eduardo Cortes Gomez, Scott M Dehm, Amina Zoubeidi, Christina A M Jamieson, Marlo Nicolas, Jesse K McKenney, Belinda B Willard, Eric E Klein, Cristina Magi-Galluzzi, Shaun R Stauffer, Song Liu, Hannelore V Heemers
Prostate cancer progression relies on the mitotic kinase citron kinase. Cancer research (2023)
Cheng Zou, Qinju He, Yuqing Feng, Mengjie Chen, Dingxiao Zhang
A m 6 Avalue predictive of prostate cancer stemness, tumor immune landscape and immunotherapy response. NAR cancer 4 (1) (2022)
Jiangling Xiong, Lianlian Yan, Cheng Zou, Kai Wang, Mengjie Chen, Bin Xu, Zhipeng Zhou, Dingxiao Zhang
Integrins regulate stemness in solid tumor: an emerging therapeutic target. Journal of hematology & oncology 14 (1) (2021)
Dingxiao Zhang, Qiang Hu, Xiaozhuo Liu, Yibing Ji, Hsueh-Ping Chao, Yan Liu, Amanda Tracz, Jason Kirk, Silvia Buonamici, Ping Zhu, Jianmin Wang, Song Liu, Dean G Tang
Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer. Nature communications 11 (1) (2020)
Cheng Zou, Ying Wan, Lingjing He, Jin Hai Zheng, Yang Mei, Junfeng Shi, Min Zhang, Zhiqiang Dong, Dingxiao Zhang
RBM38 in cancer: role and mechanism. Cellular and molecular life sciences : CMLS 78 (1) (2020)
Cheng Zou, Dingxiao Zhang
The spliceosome as a new therapeutic vulnerability in aggressive prostate cancer. Molecular & cellular oncology 7 (5) (2020)

Dingxiao Zhang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Dingxiao Zhang